Δ4-Tibolone
Appearance
Clinical data | |
---|---|
Other names | ORG-OM-38; Delta-4-Tibolone; 7α-Methylnorethisterone; 7α-Methyl-17α-ethynyl-19-nortestosterone; 17α-Ethynyl-17β-hydroxy-7α-methyl-4-estren-3-one |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C21H28O2 |
Molar mass | 312.453 g·mol−1 |
3D model (JSmol) | |
| |
|
Δ4-Tibolone (developmental code name ORG-OM-38), also known as 7α-methylnorethisterone or as 7α-methyl-17α-ethynyl-19-nortestosterone, is a synthetic androgen and progestin which was never marketed.[1][2] The compound is a major active metabolite of tibolone, which itself is a prodrug of δ4-tibolone along with 3α-hydroxytibolone and 3β-hydroxytibolone (which, in contrast to δ4-tibolone, are estrogens).[1] Tibolone and δ4-tibolone are thought to be responsible for the androgenic and progestogenic activity of tibolone, while 3α-hydroxytibolone and 3β-hydroxytibolone are thought to be responsible for its estrogenic activity.[1]
Compound | Code name | PR | AR | ER | GR | MR | SHBG | CBG |
---|---|---|---|---|---|---|---|---|
Noretynodrel | – | 6 | 0 | 2 | 0 | 0 | 0 | 0 |
Norethisterone (δ4-NYD) | – | 67–75 | 15 | 0 | 0–1 | 0–3 | 16 | 0 |
3α-Hydroxynoretynodrel | – | ? | ? | ? | ? | ? | ? | ? |
3β-Hydroxynoretynodrel | – | ? | ? | ? | ? | ? | ? | ? |
Ethinylestradiol | – | 15–25 | 1–3 | 112 | 1–3 | <1 | 0.18 | <0.1 |
Tibolone (7α-Me-NYD) | ORG-OD-14 | 6 | 6 | 1 | ? | ? | ? | ? |
Δ4-Tibolone | ORG-OM-38 | 90 | 35 | 1 | 0 | 2 | 1 | 0 |
3α-Hydroxytibolone | ORG-4094 | 0 | 3 | 4–6 | 0 | ? | ? | ? |
3β-Hydroxytibolone | ORG-301260 | 0 | 4 | 3–29 | 0 | ? | ? | ? |
7α-Methylethinylestradiol | – | ? | ? | ? | ? | ? | ? | ? |
Notes: Values are percentages (%). Reference ligands (100%) were promegestone for the PR , metribolone for the AR , E2 for the ER , DEXA for the GR , aldosterone for the MR , DHT for SHBG , and cortisol for CBG . Sources: See template. |
Template:Absolute activities of tibolone and metabolites
See also
References
- ^ a b c Kuhl H (2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration" (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
- ^ Escande A, Servant N, Rabenoelina F, Auzou G, Kloosterboer H, Cavaillès V, Balaguer P, Maudelonde T (2009). "Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites". J. Steroid Biochem. Mol. Biol. 116 (1–2): 8–14. doi:10.1016/j.jsbmb.2009.03.008. PMID 19464167.